小于胎龄儿中母体应激与胎儿胎盘皮质醇调节的关系
该巢式病例对照研究纳入西班牙巴塞罗那两个母胎医学单位的单胎妊娠,比较小于胎龄儿(SGA,n=343)与适龄儿(AGA,n=399)。SGA组母体感知压力和焦虑评分显著更高,胎盘HSD11β2 RNA表达更低而DNA甲基化无差异,羊水中皮质醇代谢物谱改变。结论认为SGA妊娠与高母体感知应激及胎儿胎盘皮质醇代谢失调相关。
要点
- SGA组母体感知压力量表评分中位数23 vs 对照组20,P<0.001,焦虑状态评分19.0 vs 16.0,P<0.001。
- SGA组胎盘HSD11β2 RNA表达中位数ΔCt 50.5 vs 对照组92.7,P=0.013,DNA甲基化水平无显著差异。
- SGA组羊水5α-四氢皮质醇浓度及5α-还原酶活性升高,6-羟基皮质醇浓度及CYP3A7活性降低。
核心结论
- SGA妊娠与母体感知应激升高及胎儿胎盘皮质醇代谢失调相关,作者认为这些结果加深了对SGA病理生理的理解,并提示干预减轻母体应激可能有益。
研究设计与样本
- 巢式病例对照研究,嵌套于大型前瞻性队列,在西班牙巴塞罗那两个母胎医学单位(BCNatal:Hospital Clinic与Sant Joan de Déu)开展。纳入单胎妊娠,SGA定义为出生体重低于第10百分位(n=343),AGA对照(n=399)。采用感知压力量表(PSS)和状态-特质焦虑量表(STAI)评估母体应激与焦虑。胎盘HSD11β2 RNA表达分析n=44 SGA和n=28 AGA,DNA甲基化分析n=89 SGA和n=34 AGA,羊水胎儿皮质醇代谢物及代谢酶活性分析n=135 SGA和n=78 AGA,采用液相色谱-串联质谱法。
诊断标准与关键数值
- SGA定义为出生体重低于第10百分位。
- SGA组母体感知压力量表评分中位数23(IQR 17-28)vs 对照组20(IQR 15-26),P<0.001。
- SGA组状态焦虑量表评分中位数19.0(IQR 14.0-29.0)vs 对照组16.0(IQR 11.0-24.0),P<0.001。
- SGA组胎盘HSD11β2 RNA表达中位数ΔCt 50.5(IQR 21.6-106.0)vs 对照组92.7(IQR 62.3-118.0),P=0.013;DNA甲基化水平均值±SD 10.7±3.0% vs 11.0±2.8%,P=0.648。
- SGA组羊水5α-四氢皮质醇浓度中位数0.09%(IQR 0.06-0.15%)vs 对照组0.07%(IQR 0.05-0.11%),P=0.020;5α-还原酶活性0.19%(IQR 0.14-0.31%)vs 0.17%(IQR 0.12-0.22%),P=0.007;6-羟基皮质醇浓度0.09%(IQR 0.06-0.11%)vs 0.11%(IQR 0.08-0.12%),P<0.001;CYP3A7活性0.19%(IQR 0.11-0.25%)vs 0.24%(IQR 0.17-0.33%),P<0.001。
临床应用与阅片要点
- 作者认为这些结果加深了对SGA病理生理的理解,并提示干预减轻母体应激可能有益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Previous research has identified an association between maternal stress, fetal growth and the expression of glucocorticoid-related genes in the placenta, particularly 11-beta hydroxysteroid dehydrogenase-2 (HSD11β2). However, to date, no studies have simultaneously explored the relationships between maternal stress, placental expression and methylation of HSD11β2, and fetal cortisol metabolites according to fetal growth. The aim of the present study was to evaluate the association between perceived antenatal maternal stress, the expression and methylation of the placental HSD11β2 gene, fetal cortisol metabolites in amniotic fluid and birth weight.
METHODS: This nested case-control study, which was part of a large prospective cohort study, was conducted at two maternofetal medicine units in Barcelona, Spain (BCNatal: Hospitals Clinic and Sant Joan de Déu). We enrolled singleton pregnancies and classified neonates as small-for-gestational age (SGA) if their birth weight was below the 10th percentile (n = 343) or as appropriate-for-gestational-age (AGA) controls (n = 399). The Perceived Stress Scale (PSS) and the State-Trait Anxiety Inventory (STAI) scores were obtained to assess maternal stress and anxiety levels. We analyzed placental HSD11β2 RNA expression (n = 44 SGA and n = 28 AGA) and DNA methylation levels (n = 89 SGA and n = 34 AGA), and fetal cortisol metabolites and the activity of metabolizing enzymes in amniotic fluid (n = 135 SGA and n = 78 AGA) using liquid chromatography-tandem mass spectrometry.
RESULTS: Median maternal perceived stress (PSS, 23 (interquartile range (IQR), 17-28) vs 20 (IQR, 15-26); P < 0.001) and median anxiety state (STAI-state, 19.0 (IQR, 14.0-29.0) vs 16.0 (IQR, 11.0-24.0); P < 0.001) scores were significantly higher in the SGA group compared with the control group. SGA cases showed lower median placental HSD11β2 RNA expression (Δ Ct, 50.5 (IQR, 21.6-106.0) vs 92.7 (IQR, 62.3-118.0); P = 0.013) with similar DNA methylation levels (mean ± SD, 10.7 ± 3.0% vs 11.0 ± 2.8%; P = 0.648) compared with AGA controls. Analysis of amniotic fluid revealed altered cortisol metabolism in SGA fetuses, with increased median 5α-tetrahydrocortisol concentration (SGA, 0.09% (IQR, 0.06-0.15%) vs controls, 0.07% (IQR, 0.05-0.11%); P = 0.020) and activity of its related enzyme (5α-reductase activity in SGA, 0.19% (IQR, 0.14-0.31%) vs controls, 0.17% (IQR, 0.12-0.22%); P = 0.007), together with a decrease in median 6-hydroxycortisol concentration (SGA, 0.09% (IQR, 0.06-0.11%) vs controls, 0.11% (IQR, 0.08-0.12%); P < 0.001) and activity of its related enzyme (CYP3A7 activity in SGA, 0.19% (IQR, 0.11-0.25%) vs controls, 0.24% (IQR, 0.17-0.33%); P < 0.001).
CONCLUSIONS: SGA pregnancy is associated with high perceived maternal stress and dysregulated fetoplacental cortisol metabolism. These results deepen our understanding of the pathophysiology of SGA and highlight the potential benefit of intervention to mitigate maternal stress. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Miranda J, Benitez L, Macías-Redondo S, et al. Maternal stress and fetoplacental cortisol regulation in small-for-gestational-age newborns. Ultrasound Obstet Gynecol. 2025. PMID: 40344310. doi:10.1002/uog.29238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。